Your browser doesn't support javascript.
FDA CAUGHT IN POLITICAL CROSSFIRE
Applied Clinical Trials ; 30(10):6, 2021.
Article in English | ProQuest Central | ID: covidwho-20244568
ABSTRACT
FDA's oversight of medical devices and diagnostics has put it in the hot seat for shortages of critical products for protecting medical personnel and for providing fast and accurate public testing for COVID infection. The result is that the White House has delayed in selecting an FDA commissioner, even though federal rules require Woodcock to vacate her acting position by mid-November unless the administration nominates a new commissioner, permitting her to continue on during the Senate confirmation process. The approval decision by CDER officials was blasted by members of Congress, the medical community and even some patient groups, but justified by the reviewers as likely to provide some benefit to some patients who lacked any alternative treatment for this devastating disease.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Type of study: Experimental Studies / Randomized controlled trials Language: English Journal: Applied Clinical Trials Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Type of study: Experimental Studies / Randomized controlled trials Language: English Journal: Applied Clinical Trials Year: 2021 Document Type: Article